Joseph J. Wolk - Dec 13, 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Exec VP, CFO
Signature
Raavi K. Deol, as attorney-in-fact for Joseph J. Wolk
Stock symbol
JNJ
Transactions as of
Dec 13, 2022
Transactions value $
-$1,351,072
Form type
4
Date filed
12/15/2022, 03:34 PM
Previous filing
Feb 17, 2022
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Gift $0 -18 -0.05% $0.00 35.8K Apr 20, 2022 Direct
transaction JNJ Common Stock Gift $0 -28 -0.08% $0.00 35.8K Apr 20, 2022 Direct
transaction JNJ Common Stock Options Exercise $1.17M +12.9K +36.09% $90.44 48.7K Dec 13, 2022 Direct
transaction JNJ Common Stock Options Exercise $135K +1.86K +3.81% $72.54 50.6K Dec 13, 2022 Direct
transaction JNJ Common Stock Sale -$333K -1.86K -3.67% $179.46 48.7K Dec 13, 2022 Direct
transaction JNJ Common Stock Sale -$2.32M -12.9K -26.52% $179.62 35.8K Dec 13, 2022 Direct F1
holding JNJ Common Stock 1.99K Dec 13, 2022 By 401k F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -1.86K -100% $0.00* 0 Dec 13, 2022 Common Stock 1.86K $72.54 Direct
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -12.9K -100% $0.00* 0 Dec 13, 2022 Common Stock 12.9K $90.44 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $179.610 to $179.670. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Stock Fund Dividends Accrued: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (11/30/2022)